RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY

Yongtao Han

Status: Enrolling

Conditions: the Records of Esophageal Cancer

Treatments: Diagnostic Test: Since the data were collected retrospectively, there were no interventions

Study type: Observational

Funder types: Other

Identifiers

NCT05570487

SichuanCHRIA

Details and patient eligibility

About

To clarify the effect of the number of lymph node dissection and the number of stations on survival

Enrollment: 1,600 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Men and women aged 18-85;
2. Histologically confirmed primary thoracic esophageal squamous cell carcinoma,
3. Staging PT1-4A, N0-3, M0 AJCC eighth edition;
4. Excluding lymph node dissection < 15,(meeting the guideline criteria)

Exclusion criteria

1. Patients with a history of previous thoracic and abdominal surgery that may affect lymphatic reflux
2. Patients with distant metastasis confirmed by imaging;
3. Patients with obvious surgical contraindications.

Trial design

1,600 participants in 4 patient groups

N0A Group

Description:

patients with negative lymph nodes and resected lymph nodes less than 15

Treatment:

Diagnostic Test: Since the data were collected retrospectively, there were no interventions

N0B Group

Description:

patients with negative lymph nodes and resected lymph nodes no less than 15

Treatment:

Diagnostic Test: Since the data were collected retrospectively, there were no interventions

N+A Group

Description:

patients with positive lymph nodes and resected lymph nodes less than 15

Treatment:

Diagnostic Test: Since the data were collected retrospectively, there were no interventions

N+B Group

Description:

patients with positive lymph nodes and resected lymph nodes no less than 15

Treatment:

Diagnostic Test: Since the data were collected retrospectively, there were no interventions